Aptinyx Inc reported $-21231000 in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -14.46M 29.41M
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Biogen BIIB:US $ 329.2M 119.3M
Daiichi Sankyo 4568:JP Y 27246M 7974M
Eli Lilly And LLY:US $ 1110.1M 280.1M
Gw Pharmaceuticals GWPH:US $ -19.68M 9.47M
Halozyme Therapeutics HALO:US $ 216.59M 125.13M
Intra Cellular Therapies ITCI:US $ -76.91M 8.16M
IONIS PHARMACEUT IONS:US $ -82M 1.12M
Marinus Pharmaceuticals MRNS:US $ -19.51M 4.32M
Neurocrine Biosciences NBIX:US $ 22.5M 19.8M
Novartis NOVN:VX SF 2758M 138M
Ultragenyx Pharmaceutical RARE:US $ -73M 49.43M
Vertex Pharmaceuticals VRTX:US $ 851.93M 785M